Partha Nandi, MD, president and CMO of Pinnacle GI Partners, told Becker’s ASC Review how prior authorizations affect finances for the company and its ASCs.
Question: How much do you estimate prior authorization to affect revenue at your center?
Dr. Partha Nandi: For the total practice, at least 35 to 40 percent of revenue is affected overall, due to the fact that a majority of infusions require prior authorization, and at least a third of upper endoscopies and anesthesia now require authorizations.
For just the ASC facility charge, it would be considerably less, as it is just about one-third of upper endoscopies and very few colonoscopy procedures. I would estimate about 15 to 20 percent of revenue is affected in the ASC.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
